Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.

Abstract

Type 1 diabetes mellitus (T1D) is considered a classical autoimmune disease which commonly starts during childhood but may appear later in adulthood in a proportion of 30-40% of affected individuals. Its development is based on a combination of a genetic predisposition and autoimmune processes that result in gradual destruction of the beta-cells of the… (More)
DOI: 10.1007/978-90-481-3271-3_28

Topics

Cite this paper

@article{Faendrich2010CustomizedCT, title={Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.}, author={Fred Faendrich and Hendrik Ungefroren}, journal={Advances in experimental medicine and biology}, year={2010}, volume={654}, pages={641-65} }